Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Degludec/Liraglutide vs Premixed Insulin in T2DM
NCT06925334Phase 4Enrolling by invitation
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec + liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Beijing Tsinghua Changgung Hospital. Started May 2024; status: enrolling by invitation.
02
Drugs
insulin degludec + liraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06925334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06925334.